Congratulations to Dr. Phil Greenberg

Congratulations to Phil Greenberg, one of the "founding members" of the UW Immunology Department, regarding his involvement with the recent launch of the biotech company Juno Therapeutics in Seattle. This $120 million biotech startup is aimed at using the immune system to treat cancer.  Partners in this effort include Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center, and Seattle Children's Research Institute.  For more information, see online at the Seattle Times, article first published on December 4, 2013: